USPTO serial 79203791
MELTECH
Reviewed by CopyMark Law Group
Reg. 5332139Status 739Renewal
- Filing date
- Status date
- Registration date
- Nov 14, 2017
- Examiner
- HALMEN, KATHERINE E
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MELTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah Anne Keefe
Sarah Anne Keefe Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Boston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, ] oncological, fungal and viral diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dexcel Pharma Technologies Ltd.
- Other trademarks owned by Dexcel Pharma Technologies Ltd.
- Other trademarks owned by Dexcel Pharma Technologies Ltd.
- Other trademarks in Class 005
- Similar marks named MELTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 31, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 29, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 7, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 10, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 3, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 14, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 13, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 22, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 14, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 7, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 7, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 7, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |